People who attend the Society of Plastics Engineers' Antec conference in May will hear keynote speeches about the development of polymer stents for treating coronary artery disease, and a molecular building-block process that helps researchers create materials.
Jim Tobin, president and chief executive officer of Boston Scientific Corp. in Natick, Mass., will explain development of the polymer technology behind his firm's Taxus coronary stent system.
Henry Weinberg, senior vice president and chief technical officer of Symyx Technologies Inc. of Santa Clara, Calif., will address something called ``combinatorial chemistry.'' The technique allows for the methodical synthesizing of large numbers of compounds by assembling molecular building blocks in many combinations.
The method of experimentation can greatly speed up how researchers evaluate new materials or formulations.
Weinberg also will discuss the specialized instruments and tools used for combinatorial chemistry, including statistical design techniques, sophisticated batch or semi-continuous parallel reactor systems and methods of characterization.
SPE-Antec will run May 1-5 in Boston. SPE is based in Brookfield.